Clinical Course, Treatment and Prognosis of Cerebrovascular Disorders in Patients with Type 2 Diabetes Mellitus
DOI:
https://doi.org/10.61788/njn.v1i21.02Keywords:
type 2 diabetes mellitus, ischemic stroke, the blood supply to the brain, cerebral vascular disordersAbstract
Type 2 diabetes mellitus (DM2) significantly increases the risk of stroke, dementia, and other cognitive and mental disorders. Atherosclerotic type of cardiovascular disorders (CVD) is the main cause of death in patients with DM2. Aim. In this review, we aimed to outline risk factors, clinical characteristics and outcomes of stroke in patients with DM2. The obtained information can be used to improve prevention, early diagnosis, and treatment of cerebral vascular disorders in DM2. Materials and Methods. We conducted a systematic review of prognostic and risk factors of cerebral vascular disorders in DM2. Our search included 50 articles from PUBMED published in the last few years. We compared statistical data from Azerbaijan with those from other countries. Results. Hyperglycemia, obesity, insulin resistance and arterial hypertension (AH) are all risk factors of brain microvascular dysfunctions in patients with diabetes mellitus. Furthermore, obesity, AH, dyslipidemias, smoking and genetic predisposition to CVD, chronic kidney disorders, and albuminuria are all risk factors of cardiovascular disorders in DM2. The possible outcomes can be a stroke, cognitive dysfunction, and depressive disorders. For Azerbaijan, main risk factors is an atherosclerotic type of CVD. Conclusion. Due to the high socio-economic burden of disease there is an urgent need in new approaches aimed at prevention, early diagnosis and treatment of cerebral vascular disorders in patients with DM2 in Azerbaijan.
References
Azərbaycan Respubikasının Dövlət Statistika Komitəsinin rəsmi internet saytı https://www.stat.gov.az/ (2018-ci il üzrə ayrı-ayrı xəstəliklər üzrə ölüm göstəricisi).
van Sloten TT, Sedaghat S, Carnethon MR, Launer LJ et al. Cerebral microvascular complications of type 2 diabetes: stroke, cognitive dysfunction, and depression // Lancet Diabetes Endocrinol. 2020 Apr;8(4):325-336. doi: 10.1016/S2213-8587(19)30405-X.
Umemura T, Kawamura T, Hotta N. Pathogenesis and neuroimaging of cerebral large and small vessel disease in type 2 diabetes: A possible link between cerebral and retinal microvascular abnormalities // J Diabetes Investig. 2017 Mar;8(2):134-148. doi: 10.1111/jdi.12545.
Jellinger PS, Handelsman Y, Rosenblit PD, Bloomgarden ZT et al. American Association of Clinical Endocrinologists and American College of Endocrinology. Guidelines for Management of Dyslipidemia and Prevention of Cardiovascular Disease // Endocr Pract.- 2017-V23(Suppl.2)-P.1-87.
Abdul Razak MK, Sultan AA. The importance of measurement of plasma fibrinogen level among patients with type- 2 diabetes mellitus // Diabetes Metab Syndr. 2019 Mar- Apr;13(2):1151-1158. doi: 10.1016/j.dsx.2019.01.049.
Əliyev R.R. Quba-Xaçmaz iqtisadi rayonunun əhalisi arasında baş beyni insultuna səbəb olan risk amillərinin yayılması // Azərbaycan təbabətinin müasir nəaliyyətləri, 2012, №2, s.127-131.
Şirəliyeva R.K., Əliyev R.R. İnsult və onun risk amillərinin yayılmasının cinsə görə fərqləri // Azərbaycan təbabətinin müasir nəaliyyətləri, 2013, №3, s.121-125.
Ширалиева Р.К., Алиев Р.Р. Эпидемиология и факторы риска инсульта в северо- восточном регионе Республики Азербайджан // «Клиническая кардионеврология» научно-практическая конференция. Журнал неврологии им. Б.М.Маньковского, 2013, том 1, №2, с. 43-49.
Əliyev R.R. Əhali arasında insultun risk amillərinin yayılmasına dair / Əməkdar Elm Xadimi, t.e.d., professor Tağı Ələkbər oğlu Tağızadənin 90 illik yubileyinə həsr olunmuş beynəlxalq elmi-praktik konfransın materialları. Bakı-2014, s. 64-67.
Shiraliyeva R.K., Aliyev R.R. Epidemiology of stroke, its risk factors and outcomes in northeast region of Azerbaijan / XIII International Congress of Medical Siences, Sofia, Bulgaria, 8-11 May, 2014 (Supplement to issue 1/2014) p.163.
Şirəliyeva R.K., Əliyev R.R. Quba-Xaçmaz iqtisadi rayonunda insultların epidemiologiyası və profilaktikası. Metodik tövsiyə, Bakı-2012, 28 s.
Əliyev R.R. İnsultların epidemiologiyası və risk amilləri: dünya və Azərbaycan / V Azərbaycan nevroloqlar konfransının toplusu, Milli nevrologiya jurnalı, xüsusi buraxılış, 2012, s.10-23.
Shiraliyeva R.K., Aliyev R.R., Hasanov R.L., Krieger D.W. Final results of stroke registry in Siyazan, Azerbaijan // Tibb və Elm Ə.Əliyev adına elmi-praktik jurnal, N1 (3) 2016, səh. 52-59.
Ismayilova Sh. Stroke statistics in Azerbaijan and around the world // Eurasian Journal of Clinical Sciences. -2020, N2, p43-52.
Lip GY, Nieuwlaat R, Pisters R, Lane DA et al. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation // Chest. 2010 Feb;137(2):263-72. doi: 10.1378/chest.09-1584.
Wolf PA, D'Agostino RB, Belanger AJ, Kannel WB. Probability of stroke: a risk profile from the Framingham Study // Stroke. 1991 Mar;22(3):312-8. doi: 10.1161/01.str.22.3.312.
Powers BJ, Danus S, Grubber JM, Olsen MK, Oddone EZ, Bosworth HB. The effectiveness of personalized coronary heart disease and stroke risk communication // Am Heart J. 2011 Apr;161(4):673-80. doi: 10.1016/j.ahj.2010.12.021.
O'Donnell MJ, Xavier D, Liu L, Zhang H et al. INTERSTROKE investigators. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study // Lancet. 2010 Jul 10;376(9735):112-23. doi: 10.1016/S0140- 6736(10)60834-3.
Feigin VL, Roth GA, Naghavi M, Parmar P et al. Global Burden of Diseases, Injuries and Risk Factors Study 2013 and Stroke Experts Writing Group. Global burden of stroke and risk factors in 188 countries, during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013 // Lancet Neurol. 2016 Aug;15(9):913-924. doi: 10.1016/S1474-4422(16)30073-4.
Boehme AK, Esenwa C, Elkind MS. Stroke Risk Factors, Genetics, and Prevention // Circ Res. 2017 Feb 3;120(3):472-495. doi: 10.1161/CIRCRESAHA.116.308398.
Khaw KT, Wareham N. Glycated hemoglobin as a marker of cardiovascular risk // Curr Opin Lipidol. 2006 Dec;17(6):637-43. doi: 10.1097/MOL.0b013e3280106b95.
Selvin E, Coresh J, Shahar E, Zhang L et al. Glycaemia (haemoglobin A1c) and incident ischaemic stroke: the Atherosclerosis Risk in Communities (ARIC) Study // Lancet Neurol. 2005 Dec;4(12):821-6. doi: 10.1016/S1474-4422(05)70227-1.
Peters SA, Huxley RR, Woodward M. Diabetes as a risk factor for stroke in women compared with men: a systematic review and meta-analysis of 64 cohorts, including 775,385 individuals and 12,539 strokes // Lancet. 2014 Jun 7;383(9933):1973-80. doi: 10.1016/S0140-6736(14)60040-4.
Zhao W, Katzmarzyk PT, Horswell R, Wang Y et al. Sex differences in the risk of stroke and HbA(1c) among diabetic patients // Diabetologia. 2014 May;57(5):918-26. doi: 10.1007/s00125-014-3190-3.
Lin CC, Li CI, Yang SY, Liu CS et al. Variation of fasting plasma glucose: a predictor of mortality in patients with type 2 diabetes // Am J Med. 2012 Apr;125(4):416.e9-18. doi: 10.1016/j.amjmed.2011.07.027.
Banerjee C, Moon YP, Paik MC, Rundek T et al. Duration of diabetes and risk of ischemic stroke: the Northern Manhattan Study // Stroke. 2012 May;43(5):1212-7. doi: 10.1161/ STROKEAHA.111.641381.
Messier C, Awad N, Gagnon M. The relationships between atherosclerosis, heart disease, type 2 diabetes and dementia // Neurol Res. 2004 Jul;26(5):567-72. doi: 10.1179/01616410 4225016263.
Суслина З.А., Лагода О.В. Атеросклероз и ишемические нарушения мозгового кровообращения // Атеротромбоз.-2009.-Т.2.-С.5-13.
Saad MI, Abdelkhalek TM, Saleh MM, Kamel MA et al. Insights into the molecular mechanisms of diabetes-induced endothelial dysfunction: focus on oxidative stress and endothelial progenitor cells // Endocrine. 2015 Dec;50(3):537-67. doi: 10.1007/s12020- 015-0709-4.
Paneni F, Volpe M, Lüscher TF, Cosentino F. SIRT1, p66(Shc), and Set7/9 in vascular hyperglycemic memory: bringing all the strands together // Diabetes. 2013 Jun;62(6):1800- 7. doi: 10.2337/db12-1648.
Weng W, Liang Y, Kimball ES, Hobbs T et al. Longitudinal Changes in Medical Services and Related Costs in a Single Cohort of Patients Newly Diagnosed With Type 2 Diabetes, 2006 to 2012 // Clin Ther. 2016 Jun;38(6):1314-1326. doi: 10.1016/j.clinthera.2016.03.032.
Mitsios JP, Ekinci EI, Mitsios GP, Churilov L et al. Relationship Between Glycated Hemoglobin and Stroke Risk: A Systematic Review and Meta-Analysis // J Am Heart Assoc. 2018 May 17;7(11):e007858. doi: 10.1161/JAHA.117.007858.
Go AS, Hylek EM, Phillips KA, Chang Y et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study // JAMA. 2001 May 9;285(18):2370-5. doi: 10.1001/jama.285.18.2370.
Van Staa TP, Setakis E, Di Tanna GL, Lane DA et al. A comparison of risk stratification schemes for stroke in 79,884 atrial fibrillation patients in general practice // J Thromb Haemost. 2011 Jan;9(1):39-48. doi: 10.1111/j.1538-7836.2010.04085.x.
Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials // Arch Intern Med. 1994 Jul 11;154(13):1449-57. Erratum in: Arch Intern Med 1994 Oct 10;154(19):2254. PMID: 8018000.
Lip GY, Nieuwlaat R, Pisters R, Lane DA et al. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation // Chest. 2010 Feb;137(2):263-72. doi: 10.1378/chest.09-1584.
Gentile NT, Seftchick MW, Huynh T, Kruus LK et al. Decreased mortality by normalizing blood glucose after acute ischemic stroke // Acad Emerg Med. 2006 Feb;13(2):174-80. doi: 10.1197/j.aem.2005.08.009.
Stratton IM, Adler AI, Neil HA, Matthews DR et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study // BMJ. 2000 Aug 12;321(7258):405-12. doi: 10.1136/bmj.321.7258.405.
Action to Control Cardiovascular Risk in Diabetes Study Group, Gerstein HC, Miller ME, Byington RP, Goff DC Jr et al. Effects of intensive glucose lowering in type 2 diabetes // N Engl J Med. 2008 Jun 12;358(24):2545-59. doi: 10.1056/NEJMoa0802743.
ADVANCE Collaborative Group, Patel A, MacMahon S, Chalmers J, Neal B, et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes // N Engl J Med. 2008 Jun 12;358(24):2560-72. doi: 10.1056/NEJMoa0802987.
UK Prospective Diabetes Study (UKPDS) Group. Turner, R.C., Holman, R.R., Stratton, I.M., Cull, C.A. et al. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). LANCET, 1998, 352(9131), 854-865.
Frier BM, Schernthaner G, Heller SR. Hypoglycemia and cardiovascular risks // Diabetes Care. 2011;34 Suppl 2(Suppl 2):S132-S137. doi:10.2337/dc11-s220.
Dormandy JA, Charbonnel B, Eckland DJ, Erdmann E. et al. PROactive Investigators. Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial // Lancet. 2005 Oct 8;366(9493):1279-89. doi: 10.1016/S0140-6736(05)67528-9.
Aldossari KK. Cardiovascular outcomes and safety with antidiabetic drugs // Int J Health Sci (Qassim). 2018 Sep-Oct;12(5):70-83. PMID: 30202411; PMCID: PMC6124835.
Мисникова, И.В., Ловалёва Ю.Ф., Древаль А.В. Риски общей и сердечно-сосудистой смертности, а также инфаркта миокарда и острого нарушения мозгового кровообращения у больных сахарным диабетом 2 типа в зависимости щт вида стартовой сахароснижающей терапии // Сахарный диабет, 2009; №4: С.72-79
Verma, S., Juni P., Mazer C.D. Pump, pipes, and filter: do SGLT2 inhibitors cover it all? // The Lancet, 2019; V.393.-P.3-5.
Wiviott SD, Raz I, Bonaca MP, Mosenzon O, et al; DECLARE-TIMI 58 Investigators. Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes // N Engl J Med. 2019 Jan 24;380(4):347-357. doi: 10.1056/NEJMoa1812389.
Rammal S.A., Almekhlafi M.A. Diabetes mellitus and stroke in the Arab world // J. Taibah Univ Med Sci.-2016-V.11.-P.295-300.
Kavanagh B.P., McCowen K.C. Glycemic control in the ICU // N Engl. J.Med.-2010.- V.363,№26.-P.2540-2546 DOI: 10.1056/NEJMcp1001115
Scott JF, Robinson GM, French JM, O'Connell JE, et al. Prevalence of admission hyperglycaemia across clinical subtypes of acute stroke // Lancet. 1999 Jan 30;353(9150):376-7. doi: 10.1016/s0140-6736(05)74948-5.
Garg R, Chaudhuri A, Munschauer F, Dandona P. Hyperglycemia, insulin, and acute ischemic stroke: a mechanistic justification for a trial of insulin infusion therapy // Stroke. 2006 Jan;37(1):267-73. doi: 10.1161/01.STR.0000195175.29487.30.
Capes SE, Hunt D, Malmberg K, Pathak P, Gerstein HC. Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview // Stroke. 2001 Oct;32(10):2426-32. doi: 10.1161/hs1001.096194.
Doğan NÖ, Akıncı E, Gümüş H, Akıllı NB, Aksel G. Predictors of Inhospital Mortality in Geriatric Patients Presenting to the Emergency Department With Ischemic Stroke // Clin Appl Thromb Hemost. 2016 Apr;22(3):280-4. doi: 10.1177/1076029614550820.
Winter A, Florin A, Marquis J. Pathogenesis and treatment of the stroke patient in a small community hospital // Angiology. 1968 Mar;19(3):141-53. doi: 10.1177/000331976801900302.
Старостина Е.Г., Генерализированное тревожное расстройство и симптомы тревоги в общемедицинской практике // Русский Медицинский Журнал, 2014; №22:С.1277-1283.
Lo JW, Crawford JD, Desmond DW, Godefroy O, et al; Stroke and Cognition (STROKOG) Collaboration. Profile of and risk factors for poststroke cognitive impairment in diverse ethnoregional groups // Neurology. 2019 Dec 10;93(24):e2257-e2271. doi: 10.1212/WNL.0000000000008612.
Miles W.R., Root H.F. Psychologic tests applied to diabetic atients // Arch Intern Med.- 1922.-V.30.-P.767-777.
DeJong, R.N. The nervous system complications of diabetes mellitus with special reference to cerebrovascular changes // J. nerv. ment. -1950, Dis.111, 181-206
Mijnhout GS, Scheltens P, Diamant M, Biessels GJ, et al. Diabetic encephalopathy: A concept in need of a definition // Diabetologia. 2006 Jun;49(6):1447-8. doi: 10.1007/s00125-006-0221-8.
Захаров В.В. Когнитивные расстройства без деменции: классификация, основные причины и лечение // Эффективная фармакотерапия.-2016.Т.1.-С.22-31.
Cukierman-Yaffe T, Gerstein HC, Williamson JD, Lazar RM, et al; Action to Control Cardiovascular Risk in Diabetes-Memory in Diabetes (ACCORD-MIND) Investigators. Relationship between baseline glycemic control and cognitive function in individuals with type 2 diabetes and other cardiovascular risk factors: the action to control cardiovascular risk in diabetes-memory in diabetes (ACCORD-MIND) trial. Diabetes Care. 2009, Feb;32(2):221-6. doi: 10.2337/dc08-1153.
Lee KO, Lee KY, Lee SY, Ahn CW, Park JS. Lacunar infarction in type 2 diabetes is associated with an elevated intracranial arterial pulsatility index // Yonsei Med J., 2007 Oct 31;48(5):802-6. doi: 10.3349/ymj.2007.48.5.802.
Chatterjee S, Peters SA, Woodward M, Mejia Arango S, et al. Type 2 Diabetes as a Risk Factor for Dementia in Women Compared With Men: A Pooled Analysis of 2.3 Million People Comprising More Than 100,000 Cases of Dementia // Diabetes Care, 2016 Feb;39(2):300-7. doi: 10.2337/dc15-1588.
Zilliox, L.A., Chadrasekaran, K., Kwan, J.Y. et al. Diabetes and Cognitive Impairment // Curr Diab Rep 16, 87 (2016). https://doi.org/10.1007/s11892-016-0775-x
Hanyu H. Diabetes-Related Dementia // Adv Exp Med Biol. 2019;1128:147-160. doi: 10.1007/978-981-13-3540-2_8. PMID: 31062329.
Munshi MN. Cognitive Dysfunction in Older Adults With Diabetes: What a Clinician Needs to Know // Diabetes Care, 2017 Apr;40(4):461-467. doi: 10.2337/dc16-1229. PMID: 28325796.
Алгоритмы специализованной медицинской помощи больным сахарным диабетом. Под редакцией И.И.Шестаковой, А.Ю.Майорова.-9-й выпуск.-М.:УП ПРИНТ; 2019.-211 с.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 National Association of Neurologists
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
